lysine has been researched along with Atherogenesis in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.96) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (29.41) | 29.6817 |
| 2010's | 28 (54.90) | 24.3611 |
| 2020's | 7 (13.73) | 2.80 |
| Authors | Studies |
|---|---|
| Battle, S; Cameron, SJ; Crabb, JW; DiDonato, JA; Fu, X; Gogonea, V; Graham, LM; Hazen, SL; Huang, Y; Wang, Z; Willard, B | 1 |
| Cai, Q; Fang, F; Ji, Y; Li, Y; Liu, W; Zhang, W | 1 |
| Barg, E; Bodetko, A; Hetman, M; Mielko, K; Młynarz, P; Placzkowska, S | 1 |
| Bao, Z; Geng, Y; Jing, L; Li, L; Pang, Q; Shao, C; Sun, Z; Wang, Z; Yan, J; Zhang, L | 1 |
| Arai, T; Hoshi, T; Nishio, T; Nogami, M; Toukairin, Y | 1 |
| Li, P; Wang, J; Xu, X; Zhang, B; Zhang, J | 1 |
| Ai, D; Cao, Y; Cheng, T; Du, J; Jiang, H; Liu, M; Liu, T; Lv, H; Lv, X; Tian, Y; Wang, B; Xiang, S; Yan, M; Zhang, H; Zhang, X; Zhou, F; Zhu, Y | 1 |
| Bao, Z; Dai, Z; Jing, L; Li, L; Shao, C; Sun, Z; Wang, Z; Xu, S; Yan, J; Ye, F; Zhu, J | 1 |
| Andrews, AJ; Fang, P; Jiang, X; Kuo, YM; Li, X; Li, Y; Luo, JJ; Maddaloni, M; Pascual, DW; Sha, X; Shao, Y; Wang, H; Yang, WY; Yang, X | 1 |
| Feskens, EJM; Hanssen, NMJ; Schalkwijk, CG; Scheijen, JLJM; Stehouwer, CDA; Van der Kallen, CJ; van Greevenbroek, MM | 1 |
| Bengtsson, E; Blixt, O; Danielsson, L; Jansson, B; Nodin, B; Nordin Fredrikson, G; Persson, N; Risinger, C; Welinder, C; Wendel, U | 1 |
| Allayee, H; Buffa, JA; Cajka, T; DiDonato, JA; Fiehn, O; Gu, X; Han, Y; Hartiala, JA; Hazen, SL; Hurd, AG; Kerby, RL; Li, L; Li, XS; Lüscher, TF; Nemet, I; Obeid, S; Rey, FE; Roberts, AB; Romano, KA; Shahen, CJ; Skye, SM; Tang, WHW; Wagner, MA; Wang, Z; Wu, Y | 1 |
| Çakatay, U; Simsek, B | 1 |
| Biocca, S; Ciccone, S; D'Arrigo, P; Desideri, A; Falconi, M; Novelli, G; Patrizi, P; Sorge, R; Viani, F | 1 |
| Chen, X; Li, L; Liang, Y; Liu, N; Wang, Z; Yan, J; Yuan, W | 1 |
| Adhikari, N; Hall, JL; Lin, YW; Liu, PS; Wei, LN | 1 |
| Furuno, S; Kawakami, M; Kobayashi, Y; Muramatsu, M; Shirai, H; Takeuchi, M; Takino, J; Yamagishi, S | 1 |
| Chambless, LE; Couper, DJ; Duncan, BB; Heiss, G; Hoogeveen, RC; Luft, VC; Pankow, JS; Schmidt, MI | 1 |
| Ding, J; Wu, H; Yang, J; Ye, M | 1 |
| Adzhubei, AA; Anashkina, AA; Brichacek, B; Bukrinsky, M; Dubrovsky, L; Hunegnaw, R; Pushkarsky, T; Sviridov, D; Üren, A; Vassylyev, DG; Vassylyeva, M | 1 |
| Bahn, G; Beisswenger, PJ; Howell, S; Reaven, PD; Saremi, A; Schwenke, DC | 1 |
| Brubaker, G; Hazen, SL; Kinter, M; Peng, DQ; Smith, JD; Willard, B; Wu, Z; Zheng, L | 1 |
| Cho, T; Jung, Y; Koschinsky, ML | 1 |
| Fukuchi, Y; Kato, Y; Miura, Y; Nabeno, Y; Naito, M; Osawa, T | 1 |
| Azuma, T; Ekuni, D; Irie, K; Kokeguchi, S; Maruyama, T; Murakami, J; Sanbe, T; Tamaki, N; Tomofuji, T; Yamamoto, T | 2 |
| Basta, G; Castagnini, M; De Caterina, R; Del Turco, S; Epistolato, MC; Righini, P; Sangiorgi, GM; Tanganelli, P | 1 |
| Bancells, C; Benítez, S; Blanco, FJ; Diercks, T; Ordóñez-Llanos, J; Sánchez-Quesada, JL; Villegas, S | 1 |
| Heinecke, JW; Oda, MN; Oram, JF; Pagani, I; Pennathur, S; Shao, B; Witztum, JL | 1 |
| Wang, XB; Wei, WL | 1 |
| Anantharamaiah, GM; Chaddha, M; Datta, G; Epand, RF; Epand, RM; Garber, DW; Handattu, SP; Keenum, TD; Mishra, VK; Monroe, CE; Palgunachari, MN | 1 |
| Itabe, H; Kato, R; Kobayashi, M; Machida, S; Sayre, LM; Shibata, N; Shibata, T; Shimozu, Y; Uchida, K; Wakita, C; Zhu, X | 1 |
| Bachschmid, MM; Cohen, RA; Hou, X; Jiang, B; Shi, C; Verbeuren, TJ; Xu, S; Zang, M | 1 |
| Ang, A; Arab, L; Crasto, C; Dalal, M; Ferrucci, L; Jardack, P; Semba, RD; Talegawkar, S; Traber, MG | 1 |
| Inaba, M; Koyama, H; Nishizawa, Y | 1 |
| An, Y; Chen, D; Jiang, Y; Liu, N; Ren, L; Wang, Z; Zhu, Y | 1 |
| Azuma, T; Ekuni, D; Endo, Y; Irie, K; Kasuyama, K; Kojima, A; Mizutani, S; Morita, M; Tamaki, N; Tomofuji, T | 1 |
| Chikazawa, M; Furuhata, A; Honda, K; Kawai, Y; Shibata, N; Shibata, T; Uchida, K | 1 |
| Furfaro, AL; Monacelli, F; Odetti, P; Pronzato, MA; Puzzo, A; Sanguineti, R; Storace, D; Traverso, N | 1 |
| Matsui, J; Matsuki, K; Matsumura, K; Murakami, H; Suda, T; Tamasawa, N; Tanabe, J; Yamashita, M | 1 |
| Gomez, D; Nguyen, AT; Owens, GK; Shankman, LS | 1 |
| MCMILLAN, GC; STARY, HC; WEIGENSBERG, BI | 1 |
| Fu, X; Green, PS; Heinecke, JW; McDonald, TO; O'Brien, KD; Oram, JF; Shao, B; Uchida, K | 1 |
| Machado, AP; Moysés, ZP; Nakandakare, ER; Passarelli, M; Pinto, RS; Quintão, EC | 1 |
| Bergt, C; Brot, N; Fu, X; Green, PS; Heinecke, JW; Oda, MN; Oram, JF; Shao, B | 1 |
| Uchida, K | 1 |
| Bárány, P; Heimbürger, O; Jogestrand, T; Lindholm, B; Maruyama, Y; Qureshi, AR; Stenvinkel, P; Suliman, ME | 1 |
| Niwa, T; Taki, K; Tsuruta, Y | 1 |
| Baynes, JW; den Hollander, NC; Graaff, R; Mulder, DJ; Smit, AJ; Smit, GP; Thorpe, SR | 1 |
| Ischiropoulos, H; Rader, DJ | 1 |
| Aldini, G; Carini, M; Facino, RM; Gamberoni, L; Regazzoni, L; Uchida, K; Vistoli, G; Yamaguchi, S | 1 |
2 review(s) available for lysine and Atherogenesis
| Article | Year |
|---|---|
AGEs and cardiovascular diseases in patients with end-stage renal diseases.
Topics: Arginine; Atherosclerosis; Cardiovascular Diseases; Female; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Lysine; Male; Oxidative Stress; Renal Dialysis; Risk Factors; Serum Albumin; Vascular Stiffness | 2012 |
Lipofuscin-like fluorophores originated from malondialdehyde.
Topics: Atherosclerosis; Dihydropyridines; Fluorescent Dyes; Humans; Immunohistochemistry; Lipid Peroxidation; Lipofuscin; Lipoproteins, LDL; Lysine; Malondialdehyde | 2006 |
49 other study(ies) available for lysine and Atherogenesis
| Article | Year |
|---|---|
The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta.
Topics: Aorta; Apolipoprotein A-I; Atherosclerosis; Humans; Isocyanates; Lipoproteins, HDL; Lysine; Plaque, Atherosclerotic; Protein Carbamylation; Proteomics; Urea | 2022 |
Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease.
Topics: Atherosclerosis; Biomarkers; Coronary Disease; Glycation End Products, Advanced; Humans; Lysine; Receptor for Advanced Glycation End Products | 2022 |
Predisposition to atherosclerosis in children and adults with trisomy 21: biochemical and metabolomic studies.
Topics: Acetates; Adolescent; Adult; Apolipoprotein A-I; Apolipoproteins B; Atherosclerosis; Cardiovascular Diseases; Child; Creatinine; Down Syndrome; Formates; Glutamine; Humans; Lysine; Proline; Pyrrolidonecarboxylic Acid; Risk Factors; Xanthines | 2023 |
N
Topics: Amputation, Surgical; Animals; Apolipoproteins E; Atherosclerosis; Cell Movement; Cells, Cultured; Diabetic Foot; Foam Cells; Humans; Lysine; Mice; Mice, Knockout; Proto-Oncogene Proteins c-vav; rac1 GTP-Binding Protein; Signal Transduction | 2020 |
Immunohistochemistry of advanced glycation end product N
Topics: Adult; Aged; Atherosclerosis; Atrial Remodeling; Autopsy; Coronary Vessels; Female; Fibrosis; Forensic Pathology; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Natriuretic Peptides; Young Adult | 2020 |
MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3.
Topics: Animals; Apoptosis; Atherosclerosis; Cells, Cultured; Disease Models, Animal; Enhancer of Zeste Homolog 2 Protein; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Lipoproteins, LDL; Lysine; Male; Methylation; Mice, Knockout, ApoE; MicroRNAs; Phosphorylation; Plaque, Atherosclerotic; Signal Transduction; STAT3 Transcription Factor | 2020 |
Macrophage K63-Linked Ubiquitination of YAP Promotes Its Nuclear Localization and Exacerbates Atherosclerosis.
Topics: Adaptor Proteins, Signal Transducing; Animals; Atherosclerosis; Cell Cycle Proteins; Cell Line; Cell Movement; Cell Nucleus; Chemokines; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Lysine; Macrophages; Male; Mice, Inbred C57BL; Models, Biological; Monocytes; Plaque, Atherosclerotic; Protein Binding; Protein Stability; Protein Transport; TNF Receptor-Associated Factor 6; Transcription Factors; Ubiquitination; Up-Regulation; YAP-Signaling Proteins | 2020 |
CML/CD36 accelerates atherosclerotic progression via inhibiting foam cell migration.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; CD36 Antigens; Cell Migration Inhibition; Cell Movement; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Foam Cells; Glycation End Products, Advanced; Lysine; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; RAW 264.7 Cells | 2018 |
IL-35 (Interleukin-35) Suppresses Endothelial Cell Activation by Inhibiting Mitochondrial Reactive Oxygen Species-Mediated Site-Specific Acetylation of H3K14 (Histone 3 Lysine 14).
Topics: Acetylation; Animals; Aorta; Aortic Diseases; Atherosclerosis; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Female; Histones; Humans; Intercellular Adhesion Molecule-1; Interleukins; Lysine; Lysophosphatidylcholines; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; Mitochondria; Protein Processing, Post-Translational; Reactive Oxygen Species; Receptors, Interleukin; Transcription Factor AP-1 | 2018 |
Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
Topics: Aged; Atherosclerosis; Body Mass Index; Cohort Studies; Diabetes Mellitus; Diet; Female; Food Handling; Glycation End Products, Advanced; Humans; Imidazoles; Lysine; Male; Middle Aged; Ornithine; Waist Circumference | 2018 |
A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer.
Topics: Animals; Antibodies, Monoclonal; Atherosclerosis; Epitope Mapping; Female; Glycation End Products, Advanced; Humans; Lysine; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Protein Array Analysis | 2018 |
Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk.
Topics: Aged; Animals; Atherosclerosis; Cardiovascular Diseases; Carnitine; Cholesterol; Choline; Disease Models, Animal; Feces; Female; Gastrointestinal Microbiome; Genome-Wide Association Study; Humans; Lysine; Male; Metabolomics; Methylamines; Mice; Mice, Inbred C57BL; Middle Aged; Nutrients; Risk Factors; Thrombosis | 2018 |
Could ornithine supplementation be beneficial to prevent the formation of pro-atherogenic carbamylated low-density lipoprotein (c-LDL) particles?
Topics: Amino Acids; Apolipoprotein B-100; Apolipoproteins; Atherosclerosis; Humans; Lipoproteins, LDL; Lysine; Models, Biological; Ornithine; Protein Carbamylation | 2019 |
Design of a novel LOX-1 receptor antagonist mimicking the natural substrate.
Topics: Animals; Atherosclerosis; Chlorocebus aethiops; COS Cells; DNA; Drug Design; Endothelium, Vascular; Humans; Ligands; Lysine; Molecular Docking Simulation; Oxygen; Phospholipids; Protein Binding; Protein Conformation; Scavenger Receptors, Class E; Substrate Specificity | 2013 |
Effects of Nε-carboxymethyl-Lysine on ERS-mediated apoptosis in diabetic atherosclerosis.
Topics: Animals; Apoptosis; Atherosclerosis; Blood Glucose; Blotting, Western; Cholesterol; Diabetes Mellitus, Experimental; Endoplasmic Reticulum Stress; Glycation End Products, Advanced; Immunohistochemistry; Lysine; Male; Mice | 2014 |
RIP140 contributes to foam cell formation and atherosclerosis by regulating cholesterol homeostasis in macrophages.
Topics: Acetylation; Adaptor Proteins, Signal Transducing; Animals; Apolipoproteins E; Atherosclerosis; ATP-Binding Cassette Transporters; Biological Transport; Cholesterol; Diet, Western; Foam Cells; Gene Knockdown Techniques; Homeostasis; Lipoproteins, LDL; Liver X Receptors; Lysine; Mice, Transgenic; Nuclear Proteins; Nuclear Receptor Interacting Protein 1; Orphan Nuclear Receptors | 2015 |
Assessment of the concentrations of various advanced glycation end-products in beverages and foods that are commonly consumed in Japan.
Topics: Antibodies; Atherosclerosis; Beverages; Biomarkers; Enzyme-Linked Immunosorbent Assay; Food Analysis; Glycation End Products, Advanced; Humans; Japan; Lysine; Risk Factors | 2015 |
Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study.
Topics: Atherosclerosis; Case-Control Studies; Cohort Studies; Diabetes Mellitus; Diabetic Angiopathies; Female; Glycation End Products, Advanced; Humans; Incidence; Lysine; Male; Middle Aged; Risk Factors | 2016 |
Endoplasmic reticulum stress-induced apoptosis: A possible role in myocardial ischemia-reperfusion injury.
Topics: Animals; Apoptosis; Atherosclerosis; Diabetes Mellitus, Experimental; Endoplasmic Reticulum Stress; Lysine; Male | 2016 |
Interaction Between HIV-1 Nef and Calnexin: From Modeling to Small Molecule Inhibitors Reversing HIV-Induced Lipid Accumulation.
Topics: Anthraquinones; Atherosclerosis; ATP Binding Cassette Transporter 1; Biological Transport; Calnexin; Cholesterol; Computer-Aided Design; Drug Design; Foam Cells; HEK293 Cells; HIV Infections; Humans; Hypolipidemic Agents; Lysine; Molecular Docking Simulation; Mutation; nef Gene Products, Human Immunodeficiency Virus; Protein Binding; Protein Interaction Domains and Motifs; Structure-Activity Relationship; Transfection | 2016 |
Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study.
Topics: Aged; Atherosclerosis; Blood Glucose; Carotid Intima-Media Thickness; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glycation End Products, Advanced; Humans; Imidazoles; Lysine; Male; Middle Aged; Oxidation-Reduction; Pyruvaldehyde; Triglycerides | 2017 |
Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function.
Topics: Amino Acid Substitution; Animals; Apolipoprotein A-I; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Cell Line; Cholesterol; Humans; Hydrogen Peroxide; Lysine; Macrophages; Methionine; Mice; Mutagenesis, Site-Directed; Oxidation-Reduction; Peroxidase; Recombinant Proteins; Tryptophan | 2008 |
Apolipoprotein(a), through its strong lysine-binding site in KIV(10'), mediates increased endothelial cell contraction and permeability via a Rho/Rho kinase/MYPT1-dependent pathway.
Topics: Actins; Amides; Aminocaproic Acid; Antifibrinolytic Agents; Apolipoproteins A; Atherosclerosis; Binding Sites; Capillary Permeability; Cell Line; Cytoskeleton; Endothelial Cells; Enzyme Inhibitors; Humans; Lysine; Myosin Light Chains; Myosin-Light-Chain Phosphatase; Phosphorylation; Plasminogen; Protein Structure, Tertiary; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; Sequence Homology, Amino Acid; Signal Transduction | 2008 |
Immunohistochemical detection of oxidative stress biomarkers, dityrosine and N(epsilon)-(hexanoyl)lysine, and C-reactive protein in rabbit atherosclerotic lesions.
Topics: Animals; Atherosclerosis; Biomarkers; C-Reactive Protein; Immunohistochemistry; Lysine; Oxidative Stress; Rabbits; Tyrosine | 2008 |
Periodontitis-induced lipid peroxidation in rat descending aorta is involved in the initiation of atherosclerosis.
Topics: Animals; Aorta, Thoracic; Aortic Diseases; Atherosclerosis; Disease Models, Animal; Down-Regulation; Fibroblasts; Hydrogen Peroxide; Lipid Peroxidation; Lipids; Lysine; Male; Microarray Analysis; Molar; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Periodontal Ligament; Periodontitis; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Superoxide Dismutase-1 | 2009 |
Vitamin C intake attenuates the degree of experimental atherosclerosis induced by periodontitis in the rat by decreasing oxidative stress.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Aorta, Thoracic; Aortic Diseases; Ascorbic Acid; Atherosclerosis; Deoxyguanosine; Endothelium, Vascular; Glutathione; Lysine; Male; Oxidative Stress; Periodontitis; Random Allocation; Rats; Rats, Wistar; Tyrosine; Vitamins | 2009 |
High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis.
Topics: Aged; Aged, 80 and over; Atherosclerosis; C-Reactive Protein; Carotid Artery Diseases; Carotid Artery, Common; Carotid Stenosis; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Glycation End Products, Advanced; Humans; Immunohistochemistry; Linear Models; Lysine; Male; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2009 |
2D-NMR reveals different populations of exposed lysine residues in the apoB-100 protein of electronegative and electropositive fractions of LDL particles.
Topics: Apolipoprotein B-100; Atherosclerosis; Humans; Isotope Labeling; Lipoproteins, LDL; Lysine; Nuclear Magnetic Resonance, Biomolecular | 2010 |
Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway.
Topics: Apolipoprotein A-I; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Carbon; Cholesterol; Foam Cells; Humans; Lipid Peroxidation; Lipoproteins, HDL; Lysine; Macrophages; Malondialdehyde; Models, Biological; Protein Structure, Tertiary; Spectrometry, Mass, Electrospray Ionization | 2010 |
[The anti-athetotic effects of heme-L-lysinate in a rabbit model of atherosclerosis].
Topics: Animals; Atherosclerosis; Carbon Monoxide; Cholesterol, Dietary; Diet, Atherogenic; Disease Models, Animal; Heme; Heme Oxygenase-1; HSC70 Heat-Shock Proteins; Lysine; Male; Rabbits; RNA, Messenger | 2010 |
Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Aortic Aneurysm; Arginine; Atherosclerosis; Cations; Cell Adhesion; Cholesterol; Endothelial Cells; Hep G2 Cells; Humans; Lipid Metabolism; Lysine; Mice; Mice, Knockout; Monocytes; Myelin Basic Protein; Peptide Fragments; Peptides; Protein Structure, Secondary; Protein Structure, Tertiary | 2010 |
Lipid peroxidation modification of protein generates Nepsilon-(4-oxononanoyl)lysine as a pro-inflammatory ligand.
Topics: Animals; Atherosclerosis; Chemokine CCL2; CHO Cells; Cricetinae; Cricetulus; Female; Gene Expression Regulation; Humans; Inflammation Mediators; Lipid Peroxidation; Lipoproteins, LDL; Lysine; Oxidation-Reduction; Scavenger Receptors, Class E; Tumor Necrosis Factor-alpha | 2011 |
High-fat diet increases and the polyphenol, S17834, decreases acetylation of the sirtuin-1-dependent lysine-382 on p53 and apoptotic signaling in atherosclerotic lesion-prone aortic endothelium of normal mice.
Topics: Acetylation; Animals; Aorta, Thoracic; Apoptosis; Atherosclerosis; Benzopyrans; Caspase 3; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; Endothelium, Vascular; Hypolipidemic Agents; Lipids; Lysine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Polyphenols; Signal Transduction; Sirtuin 1; Superoxides; Tumor Suppressor Protein p53 | 2011 |
Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study.
Topics: Adult; Aged; Atherosclerosis; Diabetes Mellitus; Diet; Female; Glycation End Products, Advanced; Humans; Kidney Diseases; Lysine; Male; Middle Aged; Young Adult | 2012 |
Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Topics: Alkaline Phosphatase; Animals; Apolipoproteins E; Apoptosis; Atherosclerosis; Blotting, Western; Bone Morphogenetic Protein 2; Cell Differentiation; Cell Line; Core Binding Factor Alpha 2 Subunit; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diet, High-Fat; Disease Progression; Glucose; Immunohistochemistry; Injections, Intravenous; Lipoproteins, LDL; Lysine; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osteogenesis; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Staining and Labeling; Time Factors; Vascular Calcification | 2012 |
Hydrogen-rich water prevents lipid deposition in the descending aorta in a rat periodontitis model.
Topics: Animals; Aorta, Thoracic; Aortic Diseases; Atherosclerosis; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hydrogen; Lipoproteins, LDL; Lysine; Male; Oxidative Stress; Periodontitis; Rats; Rats, Wistar; Reactive Oxygen Species; Statistics, Nonparametric; Tyrosine; Water | 2012 |
Monoclonal antibody against protein-bound glutathione: use of glutathione conjugate of acrolein-modified proteins as an immunogen.
Topics: Acrolein; Antibodies, Monoclonal; Atherosclerosis; Glutathione; Humans; Immunohistochemistry; Lipoproteins, LDL; Lysine; Oxidation-Reduction; Protein Binding; Proteins | 2012 |
Metalloproteinases and advanced glycation end products: coupled navigation in atherosclerotic plaque pathophysiology?
Topics: Aged; Arginine; Atherosclerosis; Biomarkers; Carotid Artery, Internal; Carotid Stenosis; Diabetic Angiopathies; Extracellular Matrix; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Inflammation Mediators; Interleukin-1alpha; Italy; Lysine; Matrix Metalloproteinase 2; Metalloproteases; Plaque, Atherosclerotic; Risk Factors; Severity of Illness Index; Tissue Inhibitor of Metalloproteinase-3 | 2012 |
Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes.
Topics: Aged; Apolipoprotein A-I; Aryldialkylphosphatase; Atherosclerosis; Biological Transport; Biomarkers; Cell Line; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Lipoproteins, HDL; Lysine; Macrophages; Male; Middle Aged; Serum Amyloid A Protein | 2013 |
Detection of histone modifications at specific gene loci in single cells in histological sections.
Topics: Animals; Atherosclerosis; Cell Lineage; Chromatin Immunoprecipitation; Epigenesis, Genetic; Fixatives; Formaldehyde; Histones; Humans; In Situ Hybridization; Lysine; Male; Methylation; Mice; Myocytes, Smooth Muscle; Myosin Heavy Chains; Paraffin Embedding | 2013 |
EFFECT OF LYSINE DEFICIENCY ON CHOLESTEROL ATHEROSCLEROSIS IN RABBITS.
Topics: Animals; Arteriosclerosis; Atherosclerosis; Body Weight; Cholesterol; Diet; Diet, Atherogenic; Growth; Lipids; Liver Cirrhosis; Lysine; Pathology; Protein Deficiency; Rabbits; Research | 1964 |
Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.
Topics: Acrolein; Adenosine Triphosphate; Amino Acid Sequence; Antibodies, Monoclonal; Apolipoprotein A-I; Arteries; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Blotting, Western; Cholesterol; Chromatography, Liquid; Crystallography, X-Ray; Electrophoresis, Polyacrylamide Gel; Humans; Immunohistochemistry; Inflammation; Lipid Peroxidation; Lipoproteins, HDL; Lysine; Mass Spectrometry; Models, Chemical; Molecular Sequence Data; Peptides; Peroxidase; Phospholipids; Protein Structure, Secondary; Sequence Homology, Amino Acid; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Temperature; Threonine; Time Factors | 2005 |
Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products.
Topics: Albumins; Animals; Atherosclerosis; Cells, Cultured; Cholesterol, HDL; Diabetes Mellitus; Enzyme Inhibitors; Glycation End Products, Advanced; Guanidines; Humans; Hypoglycemic Agents; Lysine; Macrophages, Peritoneal; Metformin; Mice | 2006 |
Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.
Topics: Apolipoprotein A-I; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Cholesterol, HDL; Foam Cells; Humans; Lysine; Methionine; Methionine Sulfoxide Reductases; Mutagenesis, Site-Directed; Oxidation-Reduction; Oxidoreductases; Peroxidase; Protein Binding; Tyrosine | 2006 |
Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
Topics: Adult; Arginine; Atherosclerosis; Biomarkers; Carotid Artery, Common; Chromatography, High Pressure Liquid; Female; Follow-Up Studies; Glycation End Products, Advanced; Homocysteine; Humans; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Organophosphates; Prognosis; Prospective Studies; Renal Dialysis; Severity of Illness Index; Time Factors; Tunica Intima; Ultrasonography | 2006 |
Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Atherosclerosis; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Chromatography, High Pressure Liquid; Creatinine; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glycation End Products, Advanced; Humans; Incidence; Indican; Lysine; Male; Middle Aged; Nephelometry and Turbidimetry; Renal Dialysis; Uremia | 2007 |
Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.
Topics: Adolescent; Adult; Arginine; Atherosclerosis; Carotid Arteries; Collagen; Female; Glycation End Products, Advanced; Glycogen Storage Disease Type I; Humans; Lysine; Male; Oxidative Stress; Risk; Skin; Tunica Intima; Tunica Media | 2007 |
'Multipurpose oxidase' in atherogenesis.
Topics: Animals; Apoptosis; Atherosclerosis; Carbamates; Cardiovascular Diseases; Cell Proliferation; Citrulline; Endothelial Cells; Humans; Inflammation; Lipoproteins, HDL; Lipoproteins, LDL; Lysine; Macrophages; Mice; Models, Biological; Muscle, Smooth; Oxidation-Reduction; Peroxidase; Scavenger Receptors, Class A; Smoking; Substrate Specificity; Thiocyanates | 2007 |
Albumin is the main nucleophilic target of human plasma: a protective role against pro-atherogenic electrophilic reactive carbonyl species?
Topics: Adult; Aldehydes; Atherosclerosis; Cysteine; Humans; Lysine; Peptides; Protective Agents; Serum Albumin | 2008 |